Home health remedies Sun Pharma the latest to recall metformin after carcinogen tests come up...

Sun Pharma the latest to recall metformin after carcinogen tests come up positive

10
0
SHARE

Once cleared by the FDA of a probable carcinogen, generic diabetes med metformin has now been the target of a growing number of recalls. This week, a seventh drugmaker has joined the metformin recall parade after finding high levels of a potential cancer-causing contaminant.

Sun Pharma recalled one lot of its Riomet ER, an extended-release version of the common diabetes med, after testing showed high levels of N-nitrosodimethylamine (NDMA), the drugmaker said Wednesday.

The recalled lot contains 747 bottles of the drug with an expiration date of October 2021, Sun said in a release. 

Whitepaper Download

Reducing the Complexity and Costs of Channel Planning and Logistics

How can you make the process of bringing your product to market less complex while also reducing costs? This Whitepaper identifies opportunities to simplify channel strategies for biopharma companies, their customers and patients. Discover how you can deliver savings and innovation to your business.

Sun is now the seventh drugmaker to launch voluntary recalls of their versions of metformin after the FDA earlier this year found high levels of NDMA, a contaminant connected to global recalls of “sartan”-based heart pressure drugs and heartburn med Zantac, in tested lots. 

RELATED: Metformin recalls continue as Bayshore pulls diabetes drug on carcinogen scare

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

fifteen − five =